ROG NYSE
Rogers Corporation
1W: -7.3%
1M: +9.7%
3M: +23.2%
YTD: +44.0%
1Y: +93.2%
3Y: -15.5%
5Y: -28.9%
$135.13
+2.73 (+2.06%)
Weekly Expected Move ±6.0%
$123
$131
$140
$148
$157
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
2 bullish
0 neutral
0 bearish
Articles (7d)
2
Daily Sentiment (7 Days)
Articles (63)
Rogers Corp. (ROG) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Roche to present new data at ASCO 2026, reinforcing giredestrant's potential to transform the treatment paradigm in early breast cancer
Is Rogers Corporation (ROG) A Good Stock To Buy Now?
Roche receives CE mark for new blood test to detect Alzheimer's pathology: Elecsys® plasma phosphorylated-tau 217 (pTau217)
Rogers Corp. SVP Sells 830 Shares Worth $113,000 as the Stock Continues Its Climb. Time to Sell?
Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics
Rogers Corp. (ROG) is a Great Momentum Stock: Should You Buy?
Meta, Ford, Willis Towers Watson And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026
Rogers Corporation Q1 2026 Earnings Call Summary
Rogers (ROG) Q1 2026 Earnings Call Transcript
Rogers forecasts Q2 adjusted EPS of $0.90 to $1.10 with adjusted EBITDA margin at 17.7% midpoint
Rogers Corp. (ROG) Q1 Earnings Beat Estimates
Rogers Q1 2026 Earnings Call: Complete Transcript
Rogers Corporation (NYSE: ROG) lifts Q1 2026 margins and posts quarterly profit - Stock Titan
Rogers Non-GAAP EPS of $0.75 beats by $0.07, revenue of $200.5M in-line
Rogers (ROG) Q2 2025 Earnings Call Transcript
Here are the major earnings after the close Tuesday
Earnings Scheduled For April 28, 2026
Rogers (NYSE:ROG) Shares Gap Up – Should You Buy?
Rogers Corp. (ROG) Soars 6.4%: Is Further Upside Left in the Stock?
Texas Instruments jumps as data center revenue surges 90%; leads analog stocks higher
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong sales growth of +6% at constant exchange rates in the first quarter of 2026; -5% in CHF due to the significant appreciation of the Swiss franc
[Ad-hoc-Mitteilung gemäss Art. 53 KR] Starkes Verkaufswachstum der Roche-Gruppe von +6% zu konstanten Wechselkursen im ersten Quartal 2026; -5% in CHF aufgrund der deutlichen Aufwertung des Schweizer Frankens
Roche’s fenebrutinib significantly reduced relapses versus standard of care to approximately one every 17 years in RMS
Roche’s ENSPRYNG (satralizumab) reduces risk of relapses by 68% demonstrating potential to become first treatment for MOGAD
FDA accepts application for Roche’s Gazyva/Gazyvaro for the treatment of the most common form of lupus
Roche receives CE mark for new Elecsys NfL blood test to detect neuroinflammation in multiple sclerosis
Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test to further safeguard the global blood supply
Rogers (NYSE:ROG) Shares Pass Above Two Hundred Day Moving Average – Here’s What Happened
Roche eröffnet neues Forschungsgebäude für das Institute of Human Biology und leistet damit Pionierarbeit im Bereich menschlicher Modellsysteme, um Entwicklung von Medikamenten zu beschleunigen
Roche inaugurates new research home for the Institute of Human Biology, pioneering human model systems to accelerate drug discovery and development
Roche launches NVIDIA AI factory to accelerate the development of new therapeutics and diagnostics solutions
Cinctive Capital Management LP Invests $5.34 Million in Rogers Corporation $ROG
Roche Annual General Meeting 2026
Assemblée générale annuelle 2026 de Roche
Roche Generalversammlung 2026
[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on phase III persevERA study in ER-positive advanced breast cancer
New England Journal of Medicine publishes phase III ALLEGORY data showing Roche’s Gazyva/Gazyvaro significantly reduces disease activity in the most common form of lupus
Roche announces positive Phase II results for petrelintide, an amylin analog developed for people living with overweight and obesity
Clearline Capital Increases Core Scientific Stake as Bitcoin Mining Becomes a Data Center Business
[Ad hoc announcement pursuant to Art. 53 LR] Roche's fenebrutinib confirms its potential as first and only BTK inhibitor for relapsing and primary progressive MS in third positive Phase III study (FENhance 1)
Clearline Capital Trims Semtech as Post-Sierra Model Drives Earnings
Media Mogul Tom Rogers: Netflix has a great path ahead after freeing itself from Warner Bros. deal
The Great Canadian Jersey Coming to the Hockey Hall of Fame
Rogers Satellite Transforming IoT Connectivity for Asset and Fleet Management Technology
Rogers Corporation Reports Fourth Quarter and Full Year 2025 Results
What Might Be Behind One Fund's New $40 Million Bet on Rogers Corporation Stock?
NervGen Pharma Appoints Adam Rogers as Chief Executive Officer to Continue Leading the Company's Growth and Execution of Its Mission in Spinal Cord Injury
Nuance Investments LLC Lowers Position in Rogers Corporation $ROG
Rogers Sugar Delivers Strong First Quarter Results, Driven by Focus on Execution in Both Business Segments
Rogers Sugar Inc. Declares Dividend to Shareholders
REMINDER - Rogers Sugar Inc.: Conference Call – 1st Quarter 2026 Results
Rogers Corporation Schedules Fourth Quarter 2025 Earnings Call for February 17
Y Intercept Hong Kong Ltd Grows Position in Rogers Corporation $ROG
Rogers Sugar: Revisiting The Thesis As LEAP Is Delayed
Rogers Sugar Inc.: Conference Call – 1st Quarter 2026 Results
Rogers (NYSE:ROG) Stock Crosses Above 200 Day Moving Average – Should You Sell?
Rogers Corporation $ROG Shares Bought by Geode Capital Management LLC
Rogers Sugar Inc. Declares Dividend to Shareholders
Rogers Sugar Reports Strong Profitability Growth in 2025, Fuelled by our Focus on Servicing our Customers and Disciplined Execution
REMINDER — Rogers Sugar Inc.: Conference Call – 4th Quarter 2025 Results
Creative Planning Has $2.50 Million Stock Holdings in Rogers Corporation $ROG